Product Life Cycle Management

Reflect on why following a product life-cycle management perspective is a useful way to pursue commercialization of new healthcare products.  For example, why should regulatory affairs professionals be concerned with post-market surveillance by FDA at the beginning stages of product development.  In this specific case, pre-clinical studies may not tell a product manufacturer anything about a how a new investigational compound will behave in clinical populations, for example, with respect to drug-drug interactions.